| Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells A Le Moignic, V Malard, T Benvegnu, L Lemiègre, M Berchel, PA Jaffrès, ... Journal of controlled release 278, 110-121, 2018 | 103 | 2018 |
| Engineered mesenchymal stem cells as vectors in a suicide gene therapy against preclinical murine models for solid tumors I Amara, E Pramil, C Senamaud-Beaufort, A Devillers, R Macedo, ... Journal of Controlled Release 239, 82-91, 2016 | 27 | 2016 |
| Efficacy of DNA vaccines forming e7 recombinant retroviral virus-like particles for the treatment of human papillomavirus-induced cancers G Lescaille, F Pitoiset, R Macedo, C Baillou, C Huret, D Klatzmann, ... Human gene therapy 24 (5), 533-544, 2013 | 24 | 2013 |
| Immune responses in COVID-19 and tuberculosis coinfection: A scoping review K Flores-Lovon, B Ortiz-Saavedra, LA Cueva-Chicaña, S Aperrigue-Lira, ... Frontiers in immunology 13, 992743, 2022 | 17 | 2022 |
| Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles R Macedo, J Rochefort, M Guillot-Delost, K Tanaka, A Le Moignic, ... Oncoimmunology 5 (7), e1164363, 2016 | 16 | 2016 |
| TGM4: an immunogenic prostate-restricted antigen ZA Lopez-Bujanda, A Obradovic, TR Nirschl, L Crowley, R Macedo, ... Journal for immunotherapy of cancer 9 (6), 2021 | 14 | 2021 |
| Orthovoltage X-rays exhibit increased efficacy compared with γ-rays in preclinical irradiation BI Bell, J Vercellino, NP Brodin, C Velten, LSY Nanduri, PKB Nagesh, ... Cancer research 82 (15), 2678-2691, 2022 | 11 | 2022 |
| Efecto de la terapia temprana con L-arginina en el crecimiento intrauterino restringido en la preclampsia. Estudio aleatorizado en mujeres latinoamericanas JE Valdivia-Silva, K López-Molina, R Macedo Progresos de obstetricia y ginecología 52 (2), 89-98, 2009 | 6 | 2009 |
| Defining biomarkers in oral cancer according to smoking and drinking status J Rochefort, I Karagiannidis, C Baillou, L Belin, M Guillot-Delost, ... Frontiers in Oncology 12, 1068979, 2023 | 5 | 2023 |
| Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature R Macedo, C Pasin, A Ganetsky, D Harle, XK Wang, K Belay, LP Richman, ... Transplantation and cellular therapy 28 (1), 18. e1-18. e10, 2022 | 5 | 2022 |
| Increased relative biological effectiveness of orthovoltage X-rays compared to γ-rays in preclinical Irradiation BI Bell, J Vercellino, NP Brodin, C Velten, LSY Nanduri, KE Tanaka, ... bioRxiv, 2022.02. 18.480594, 2022 | 2 | 2022 |
| European society of gene and cell therapy french society of cell and gene therapy collaborative congress 2012 october 25–29, 2012 palais des congrès de versailles, France T VandenDriessche, RA Pearson, RJ Chandler, CC Bartholomae, ... Hum. Gene Ther 23 (10), 2012 | 2 | 2012 |
| Development of therapeutic vaccine strategies and pre-clinical animal tumor models for head and neck cancers RM Gonzales Université Pierre et Marie Curie-Paris VI, 2015 | 1 | 2015 |
| Immunité et cancers des voies aéro-digestives supérieures 2e partie. Immunothérapies des cancers des VADS G Lescaille, J Rochefort, R Macedo, A Le Moignic, C Baillou, V Mateo, ... Médecine Buccale Chirurgie Buccale 20 (4), 245-252, 2014 | 1 | 2014 |
| Immunité et cancers des voies aéro-digestives supérieures 1re partie: Réponses immunitaires et échappement tumoral G Lescaille, J Rochefort, R Macedo, A Le Moignic, C Baillou, V Mateo, ... Médecine Buccale Chirurgie Buccale 20 (3), 155-160, 2014 | 1 | 2014 |
| Characteristics of Alloreactive T-Cell Clones That Predict Early Development of Acute GvHD Following Allogeneic HCT XK Wang, A Uzuni, K Belay, DW Harle, CA Gordillo, RJ Macedo, ... Blood 142, 2042, 2023 | | 2023 |
| Immune priming with low intensity focused ultrasound and radiation therapy in murine breast cancer MM Schumacher, CG Chavez, S Singh, C Karunakaran, S Pandey, ... Cancer Research 82 (12_Supplement), 4201-4201, 2022 | | 2022 |
| Glucagon-like Peptide-2 (GLP-2) Treatment Reduces Gvhd-Related Mortality in a Pre-Clinical Transplant Model Via Expansion of Macrophages with Tolerogenic Potential DW Harle, RJM Gonzales, FD Rozenberg, A Matschiner, R Bansal, ... Blood 136, 26-28, 2020 | | 2020 |
| 168 A novel prostate-restricted tumor-associated antigen: a potential therapeutic target ZAL Bujanda, A Obradovic, T Nirschl, T O’Donnell, U Laserson, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| Coexpression of effector T cell-associated chemokine receptors defines T-cell subsets with different roles in antitumor response and toxicity of dual checkpoint blockade. RJM Gonzales, D Harle, XK Wang, A Matschiner, R Reshef CANCER IMMUNOLOGY RESEARCH 8 (3), 86-87, 2020 | | 2020 |
geraldine lescaillePU PH, paris 7, APHPDirección de correo verificada de psl.aphp.fr
